April 2024
1. HARRIS E
   Therapy Delivered by Nonspecialists Improved Postpartum Mental Health.
   JAMA. 2024;331:1265-1266.
   

   >> Share

   
   
2. NITZAN I, Philips R, White RD
   Screening Recommendations and Treatments for Postpartum Depression.
   JAMA. 2024;331:1153-1154.
   

   >> Share

   
   
3. MOORE SIMAS TA, Whelan A, Byatt N
   Screening Recommendations and Treatments for Postpartum Depression-Reply.
   JAMA. 2024;331:1154.
   

   >> Share

   
   March 2024
4. VOELKER R
   What Is Perinatal Depression?
   JAMA. 2024 Mar 14. doi: 10.1001/jama.2024.0434.
   

   >> Share

   
   February 2024
5. HARRIS E
   Meta-Analysis: Exercise as Effective as Therapy for Treating Depression.
   JAMA. 2024 Feb 28. doi: 10.1001/jama.2024.1121.
   

   >> Share

   
   January 2024
6. HARRIS E
   Machine Learning Algorithms Failed to Find Depression Biomarker.
   JAMA. 2024 Jan 31. doi: 10.1001/jama.2023.28339.
   

   >> Share

   
   
7. HARRIS E
   Perinatal Depression Tied to Higher Long-Term Risk of Death.
   JAMA. 2024 Jan 31. doi: 10.1001/jama.2023.28341.
   

   >> Share

   
   
8. THORNBURG B, Kennedy-Hendricks A, Rosen JD, Eisenberg MD, et al
   Anxiety and Depression Symptoms After the Dobbs Abortion Decision.
   JAMA. 2024;331:294-301.
   

   >> Share

   
   November 2023
9. MOORE SIMAS TA, Whelan A, Byatt N
   Postpartum Depression-New Screening Recommendations and Treatments.
   JAMA. 2023 Nov 27. doi: 10.1001/jama.2023.21311.
   

   >> Share

   
   October 2023
10. HARRIS E
    LSD Use Increasing More Among People With Depression.
    JAMA. 2023 Oct 25. doi: 10.1001/jama.2023.20630.
    

    >> Share

    
    
11. HARRIS E
    Esketamine More Effective Than Quetiapine for Hard-to-Treat Depression.
    JAMA. 2023 Oct 18. doi: 10.1001/jama.2023.19797.
    

    >> Share

    
    September 2023
12. AL-KAISEY AM, Parameswaran R, Bryant C, Anderson RD, et al
    Atrial Fibrillation Catheter Ablation vs Medical Therapy and Psychological Distress: A Randomized Clinical Trial.
    JAMA. 2023;330:925-933.
    

    >> Share

    
    
13. RAISON CL, Sanacora G, Woolley J, Heinzerling K, et al
    Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.
    JAMA. 2023;330:843-853.
    

    >> Share

    
    August 2023
14. RUBIN R
    A Fast-Acting Pill Received Approval for Postpartum Depression-Is It a Game Changer?
    JAMA. 2023 Aug 23. doi: 10.1001/jama.2023.16499.
    

    >> Share

    
    July 2023
15. HARRIS E
    Depression After Head Injury Might Be Separate Disorder.
    JAMA. 2023 Jul 12. doi: 10.1001/jama.2023.12543.
    

    >> Share

    
    June 2023
16. JIN J
    Screening for Depression and Suicide Risk in Adults.
    JAMA. 2023;329:2102.
    

    >> Share

    
    
17. O'CONNOR EA, Perdue LA, Coppola EL, Henninger ML, et al
    Depression and Suicide Risk Screening: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2023;329:2068-2085.
    

    >> Share

    
    
18. BARRY MJ, Nicholson WK, Silverstein M, Chelmow D, et al
    Screening for Depression and Suicide Risk in Adults: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2023;329:2057-2067.
    

    >> Share

    
    May 2023
19. HARRIS E
    Ketamine Noninferior to Electroconvulsive Therapy For Depression.
    JAMA. 2023 May 31. doi: 10.1001/jama.2023.9604.
    

    >> Share

    
    March 2023
20. HARRIS E
    Combining Drugs Improved Hard-to-Treat Depression in Older Adults.
    JAMA. 2023 Mar 15. doi: 10.1001/jama.2023.3309.
    

    >> Share

    
    February 2023
21. LEICHSENRING F, Heim N, Leweke F, Spitzer C, et al
    Borderline Personality Disorder: A Review.
    JAMA. 2023;329:670-679.
    

    >> Share

    
    November 2022
22. NELSON HD, Darney BG, Ahrens K, Burgess A, et al
    Associations of Unintended Pregnancy With Maternal and Infant Health Outcomes: A Systematic Review and Meta-analysis.
    JAMA. 2022;328:1714-1729.
    

    >> Share

    
    October 2022
23. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
    Screening for Depression and Suicide Risk in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2022 Oct 11. pii: 2797145. doi: 10.1001/jama.2022.16946.
    

    >> Share

    
    
24. JIN J
    Screening for Depression and Suicide Risk in Children and Adolescents.
    JAMA. 2022 Oct 11. pii: 2797147. doi: 10.1001/jama.2022.18187.
    

    >> Share

    
    
25. BUKSTEIN OG
    Screening for Adolescent Depression and Suicide Risk.
    JAMA. 2022 Oct 11. pii: 2797148. doi: 10.1001/jama.2022.15223.
    

    >> Share

    
    
26. VISWANATHAN M, Wallace IF, Cook Middleton J, Kennedy SM, et al
    Screening for Depression and Suicide Risk in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2022 Oct 11. pii: 2797146. doi: 10.1001/jama.2022.16310.
    

    >> Share

    
    August 2022
27. GOODWIN RD, Davidson L
    Prevalence of Cigarette Smoking Among US Adults With Major Depression or Substance Use Disorders.
    JAMA. 2022;328:585.
    

    >> Share

    
    
28. HAN B, Tipperman D, Compton WM
    Prevalence of Cigarette Smoking Among US Adults With Major Depression or Substance Use Disorders-Reply.
    JAMA. 2022;328:585-586.
    

    >> Share

    
    July 2022
29. IOSIFESCU DV
    Pharmacogenomic Testing for Next-Step Antidepressant Selection: Still a Work in Progress.
    JAMA. 2022;328:146-148.
    

    >> Share

    
    
30. OSLIN DW, Lynch KG, Shih MC, Ingram EP, et al
    Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial.
    JAMA. 2022;328:151-161.
    

    >> Share

    
    June 2022
31. SLOMSKI A
    Even Low Amounts of Physical Activity Reduce Depression Risk.
    JAMA. 2022;327:2066.
    

    >> Share

    
    May 2022
32. SLOMSKI A
    Antidepressant Combinations Compared With Monotherapy.
    JAMA. 2022;327:1641.
    

    >> Share

    
    April 2022
33. HAN B, Volkow ND, Blanco C, Tipperman D, et al
    Trends in Prevalence of Cigarette Smoking Among US Adults With Major Depression or Substance Use Disorders, 2006-2019.
    JAMA. 2022;327:1566-1576.
    

    >> Share

    
    
34. CHEN MH, Liang CS, Su KP
    Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression.
    JAMA. 2022;327:1291-1292.
    

    >> Share

    
    
35. LIANG CS, Tseng PT, Su KP
    Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression.
    JAMA. 2022;327:1290-1291.
    

    >> Share

    
    
36. OKEREKE OI, Mischoulon D, Manson JE
    Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression-Reply.
    JAMA. 2022;327:1292.
    

    >> Share

    
    January 2022
37. NIKNAM BA, Zubizarreta JR
    Using Cardinality Matching to Design Balanced and Representative Samples for Observational Studies.
    JAMA. 2022;327:173-174.
    

    >> Share

    
    
38. HAHN EE, Munoz-Plaza CE, Pounds D, Lyons LJ, et al
    Effect of a Community-Based Medical Oncology Depression Screening Program on Behavioral Health Referrals Among Patients With Breast Cancer: A Randomized Clinical Trial.
    JAMA. 2022;327:41-49.
    

    >> Share

    
    December 2021
39. OKEREKE OI, Vyas CM, Mischoulon D, Chang G, et al
    Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial.
    JAMA. 2021;326:2385-2394.
    

    >> Share

    
    November 2021
40. ABBASI J
    Closed Loop Device May Alleviate Treatment-Resistant Depression.
    JAMA. 2021;326:1785.
    

    >> Share

    
    
41. CHEN MH, Tseng PT, Liang CS
    Depressive Symptom Assessment in Medically Ill Patients.
    JAMA. 2021;326:1748.
    

    >> Share

    
    
42. HAHN SR
    Depressive Symptom Assessment in Medically Ill Patients.
    JAMA. 2021;326:1748-1749.
    

    >> Share

    
    
43. BAUMGART P, Garrick T
    Depressive Symptom Assessment in Medically Ill Patients-Reply.
    JAMA. 2021;326:1749.
    

    >> Share

    
    
44. CHRISTENSEN J, Trabjerg BB, Sun Y, Dreier JW, et al
    Association of Maternal Antidepressant Prescription During Pregnancy With Standardized Test Scores of Danish School-aged Children.
    JAMA. 2021;326:1725-1735.
    

    >> Share

    
    October 2021
45. SLOMSKI A
    Pediatric Depression and Anxiety Doubled During the Pandemic.
    JAMA. 2021;326:1246.
    

    >> Share

    
    September 2021
46. SLOMSKI A
    Novel Oral Drug Rapidly Treats Postpartum Depression.
    JAMA. 2021;326:800.
    

    >> Share

    
    August 2021
47. 
    A Simple Approach to Relieve Teens' Anxiety and Depression.
    JAMA. 2021;326:591.
    

    >> Share

    
    June 2021
48. BAUMGART P, Garrick T
    Assessment of Depressive Symptoms in Medically Ill Patients.
    JAMA. 2021;325:2497-2498.
    

    >> Share

    
    
49. LISS DT, Uchida T, Wilkes CL, Radakrishnan A, et al
    General Health Checks in Adult Primary Care: A Review.
    JAMA. 2021;325:2294-2306.
    

    >> Share

    
    May 2021
50. TOROUS J
    Digital Interventions for Adults With Symptoms of Depression and Children and Adolescents With Symptoms of Obsessive-Compulsive Disorder.
    JAMA. 2021;325:1839-1840.
    

    >> Share

    
    
51. ASPVALL K, Andersson E, Melin K, Norlin L, et al
    Effect of an Internet-Delivered Stepped-Care Program vs In-Person Cognitive Behavioral Therapy on Obsessive-Compulsive Disorder Symptoms in Children and Adolescents: A Randomized Clinical Trial.
    JAMA. 2021;325:1863-1873.
    

    >> Share

    
    
52. ARAYA R, Menezes PR, Claro HG, Brandt LR, et al
    Effect of a Digital Intervention on Depressive Symptoms in Patients With Comorbid Hypertension or Diabetes in Brazil and Peru: Two Randomized Clinical Trials.
    JAMA. 2021;325:1852-1862.
    

    >> Share

    
    April 2021
53. EL-BATTRAWY I, Behnes M, Akin I
    Depression and Incident Cardiovascular Disease.
    JAMA. 2021;325:1679-1680.
    

    >> Share

    
    
54. DAVIDSON KW, Pennells L, Di Angelantonio E
    Depression and Incident Cardiovascular Disease-Reply.
    JAMA. 2021;325:1680.
    

    >> Share

    
    
55. SLOMSKI A
    Low-Income African American Women With Hypertension and Depression.
    JAMA. 2021;325:1602.
    

    >> Share

    
    March 2021
56. BAGLEY SM
    I Am Not Burned Out.
    JAMA. 2021;325:1155-1156.
    

    >> Share

    
    
57. MORIN L, Savale L, Pham T, Colle R, et al
    Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19.
    JAMA. 2021 Mar 17. pii: 2777787. doi: 10.1001/jama.2021.3331.
    

    >> Share

    
    December 2020
58. RUBIN R
    Postpartum Depression Persists Longer Than Previously Thought.
    JAMA. 2020;324:2475.
    

    >> Share

    
    
59. HARSHFIELD EL, Pennells L, Schwartz JE, Willeit P, et al
    Association Between Depressive Symptoms and Incident Cardiovascular Diseases.
    JAMA. 2020;324:2396-2405.
    

    >> Share

    
    October 2020
60. BAUM A, Wisnivesky J, Basu S, Siu AL, et al
    Association of Geographic Differences in Prevalence of Uncontrolled Chronic Conditions With Changes in Individuals' Likelihood of Uncontrolled Chronic Conditions.
    JAMA. 2020;324:1429-1438.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share